Terug
Dagbereik
€ 10,39
€ 11,00
52-Weeksbereik
€ 5,90
€ 14,51
Volume
547.472
50D / 200D Gem.
€ 12,71
/
€ 10,01
Vorige Slotkoers
€ 10,29
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,7 | 0,2 |
| P/B | 1,6 | 3,0 |
| ROE % | -16,2 | 3,6 |
| Net Margin % | -30,8 | 3,8 |
| Rev Growth 5Y % | 48,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 12,50
+14.5%
Low: € 6,00
High: € 18,00
Forward WPA
-€ 3,32
Omzet Sch.
93,17M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,63
-€ 1,30 – -€ 0,17
|
276,89M | 6 |
| FY2029 |
-€ 1,87
-€ 3,84 – -€ 0,49
|
208,60M | 6 |
| FY2028 |
-€ 2,14
-€ 3,75 – € 2,83
|
160,81M | 8 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -€ 0,51 | -€ 1,10 | -114,2% |
| 2025-11-05 | -€ 0,75 | -€ 0,48 | +36,0% |
| 2025-08-06 | -€ 0,87 | -€ 0,84 | +3,4% |
| 2025-05-01 | -€ 0,86 | € 1,14 | +232,6% |
| 2025-02-11 | -€ 1,07 | -€ 0,63 | +41,1% |
| 2024-10-30 | -€ 0,88 | -€ 0,68 | +22,7% |
| 2024-07-30 | -€ 0,72 | -€ 0,49 | +31,9% |
| 2024-05-07 | -€ 1,48 | -€ 0,97 | +34,5% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 48,78% annually over 5 years — strong growth
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -275,70M
PEG of 0,18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 49,08%
Capital efficient — spends only 0,72% of revenue on capex
Groei
Revenue Growth (5Y)
48,78%
Revenue (1Y)-0,30%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-16,23%
ROIC-19,48%
Net Margin-30,77%
Op. Margin-43,75%
Veiligheid
Debt / Equity
0,02
Current Ratio4,92
Interest Coverage0,00
Waardering
P/E Ratio
-8,68
Forward P/EN/A
P/B Ratio1,62
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,30% | Revenue Growth (3Y) | 82,90% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 48,78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 262,60M | Net Income (TTM) | -80,80M |
| ROE | -16,23% | ROA | -11,26% |
| Gross Margin | 98,02% | Operating Margin | -43,75% |
| Net Margin | -30,77% | Free Cash Flow (TTM) | -275,70M |
| ROIC | -19,48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,92 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,68 | Forward P/E | N/A |
| P/B Ratio | 1,62 | P/S Ratio | 2,67 |
| PEG Ratio | 0,18 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 7,53 | Fwd Earnings Yield | N/A |
| FCF Yield | -39,31% | ||
| Market Cap | 701,33M | Enterprise Value | 566,93M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 262,60M | 263,40M | 78,50M | 131,40M | 53,60M |
| Net Income | -80,80M | -198,90M | -367,30M | -282,50M | -191,00M |
| EPS (Diluted) | -1,28 | -2,77 | -6,62 | -5,31 | -3,82 |
| Gross Profit | 257,40M | 263,40M | 78,50M | 131,40M | 53,60M |
| Operating Income | -114,90M | -250,20M | -401,50M | -263,20M | -188,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 717,90M | 1,09B | 1,30B | 1,27B | 1,58B |
| Total Liabilities | 284,00M | 529,70M | 644,60M | 703,90M | 799,90M |
| Shareholders' Equity | 433,90M | 561,70M | 660,00M | 564,90M | 781,70M |
| Total Debt | 8,50M | 9,70M | 3,20M | 5,50M | 5,00M |
| Cash & Equivalents | 142,90M | 100,50M | 311,70M | 81,30M | 108,30M |
| Current Assets | 700,70M | 1,07B | 1,28B | 1,24B | 1,55B |
| Current Liabilities | 142,50M | 229,80M | 257,10M | 295,10M | 261,70M |